Polypeptide having xylanase activity

US10550375B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10550375-B2
Application numberUS-201515116281-A
CountryUS
Kind codeB2
Filing dateJan 30, 2015
Priority dateJan 31, 2014
Publication dateFeb 4, 2020
Grant dateFeb 4, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to an isolated polypeptide having xylanase activity, selected from the group consisting of: a) a polypeptide comprising an amino acid sequence having at least 87% identity with SEQ ID NO: 1; b) a polypeptide encoded by a polynucleotide having at least 87% identity with SEQ ID NO:2; or c) a fragment of a polypeptide of a) or b) which fragment has xylanase activity.

First claim

Opening claim text (preview).

The invention claimed is: 1. A polypeptide having xylanase activity, selected from the group consisting of: (a) a polypeptide comprising an amino acid sequence having at least 94% identity with SEQ ID NO: 1; or (b) a polypeptide encoded by a polynucleotide having at least 94% identity with SEQ ID NO:2. 2. The polypeptide according to claim 1 , wherein the polypeptide comprises the amino acid sequence of SEQ ID No. 1. 3. The polypeptide of claims 1 or 2 wherein the polypeptide is encoded by the polynucleotide of SEQ ID No. 2. 4. The polypeptide of claims 1 or 2 , wherein the polypeptide is an endo-1,4-β-xylanase. 5. The polypeptide of claims 1 or 2 , wherein the polypeptide has at least 50% residual activity of xylanase activity after incubation at 65° C. for 10 minutes at pH 6 and/or has at least 80% residual activity of xylanase activity after incubation at 61° C. for 10 minutes at pH 6. 6. The polypeptide according to claim 1 , wherein the polypeptide has a residual activity of at least 70% when incubated with 0.2 mg/ml pepsin in a buffered solution at pH 3.5 for two hours at a temperature of 40° C. 7. The polypeptide according to claim 1 , wherein the polypeptide solubilizes arabinoxylans without increasing viscosity in a reaction medium. 8. A feed or feedstuff comprising the polypeptide of claims 1 or 2 . 9. A method for producing the polypeptide of claims 1 or 2 comprising (a) cultivating a host cell comprising a polynucleotide having at least 94% identity with SEQ ID No. 2 under conditions conducive for production of the polypeptide; and (b) recovering the polypeptide. 10. The method according to claim 9 wherein the polypeptide produced is isolated and/or purified. 11. A method for solubilizing arabinoxylan in a xylan-containing material by contacting the xylan-containing material with the polypeptide of claims 1 or 2 . 12. The method of claim 11 wherein the arabinoxylan is insoluble arabinoxylan (AXinsol). 13. The method of claim 11 wherein the xylan-containing material is selected from one or more of the group consisting of: a feed or feedstuff; a feed component; a grain-based material; a mash; a wort; a malt; malted barley; an adjunct, a barley mash; and a cereal flour. 14. The method of claim 13 wherein the feed or feedstuff or feed component comprises or consists of corn, Distillers Dried Grain Solubles (DDGS), corn based Distillers Dried Grain Solubles (cDDGS), wheat, wheat bran or a combination thereof. 15. The method of claim 11 wherein the polypeptide is used in combination with one or more of the enzymes selected from the group consisting of endoglucanases (E.C. 3.2.1.4) celliobiohydrolases (E.C. 3.2.1.91), β-glucosidases (E.C. 3.2.1.21), cellulases (E.C. 3.2.1.74), lichenases (E.C. 3.2.1.73), lipases (E.C. 3.1.1.3), lipid acyltransferases (E.C. 2.3.1.x), phospholipases (E.C. 3.1.1.4, E.C. 3.1.1.32 and E.C. 3.1.1.5), 6-phytase (E.C. 3.1.3.26) 3-phytase (E.C. 3.1.3.8), amylases, alpha-amylases (E.C. 3.2.1.1), xylanases (E.C. 3.2.1.8, E.C. 3.2.1.32, E.C. 3.2.1.37, E.C. 3.2.1.72, and E.C. 3.2.1.136), glucoamylases (E.C. 3.2.1.3), hemicellulases, subtilisin (E.C. 3.4.21.62) bacillolysin (E.C. 3.4.24.28) alkaline serine proteases (E.C. 3.4.21.x) akeratinases (E.C. 3.4.x.x), debranching enzymes, cutinases, esterases and β-mannanase (E.C. 3.2.1.78). 16. The method of claim 12 wherein the polypeptide is used in combination with one or more of the enzymes selected from the group consisting of endoglucanases (E.C. 3.2.1.4) celliobiohydrolases (E.C. 3.2.1.91), β-glucosidases (E.C. 3.2.1.21), cellulases (E.C. 3.2.1.74), lichenases (E.C. 3.2.1.73), lipases (E.C. 3.1.1.3), lipid acyltransferases (E.C. 2.3.1.x), phospholipases (E.C. 3.1.1.4, E.C. 3.1.1.32 and E.C. 3.1.1.5), 6-phytase (E.C. 3.1.3.26) 3-phytase (E.C. 3.1.3.8), amylases, alpha-amylases (E.C. 3.2.1.1), xylanases (E.C. 3.2.1.8, E.C. 3.2.1.32, E.C. 3.2.1.37, E.C. 3.2.1.72, and E.C. 3.2.1.136), glucoamylases (E.C. 3.2.1.3), hemicellulases, subtilisin (E.C. 3.4.21.62) bacillolysin (E.C. 3.4.24.28) alkaline serine proteases (E.C. 3.4.21.x) akeratinases (E.C. 3.4.x.x), debranching enzymes, cutinases, esterases and β-mannanase (E.C. 3.2.1.78). 17. The method of claim 13 wherein the polypeptide is used in combination with one or more of the enzymes selected from the group consisting of endoglucanases (E.C. 3.2.1.4) celliobiohydrolases (E.C. 3.2.1.91), β-glucosidases (E.C. 3.2.1.21), cellulases (E.C. 3.2.1.74), lichenases (E.C. 3.2.1.73), lipases (E.C. 3.1.1.3), lipid acyltransferases (E.C. 2.3.1.x), phospholipases (E.C. 3.1.1.4, E.C. 3.1.1.32 and E.C. 3.1.1.5), 6-phytase (E.C. 3.1.3.26) 3-phytase (E.C. 3.1.3.8), amylases, alpha-amylases (E.C. 3.2.1.1), xylanases (E.C. 3.2.1.8, E.C. 3.2.1.32, E.C. 3.2.1.37, E.C. 3.2.1.72, and E.C. 3.2.1.136), glucoamylases (E.C. 3.2.1.3), hemicellulases, subtilisin (E.C. 3.4.21.62) bacillolysin (E.C. 3.4.24.28) alkaline serine proteases (E.C. 3.4.21.x) akeratinases (E.C. 3.4.x.x), debranching enzymes, cutinases, esterases and β-mannanase (E.C. 3.2.1.78).

Assignees

Inventors

Classifications

  • Xylan endo-1,3-beta-xylosidase (3.2.1.32), i.e. endo-1,3-beta-xylanase · CPC title

  • Enzymes · CPC title

  • Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents · CPC title

  • Alternative feeds for fish, e.g. in aquacultures · CPC title

  • for aquatic animals, e.g. fish, crustaceans or molluscs · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10550375B2 cover?
The present invention relates to an isolated polypeptide having xylanase activity, selected from the group consisting of: a) a polypeptide comprising an amino acid sequence having at least 87% identity with SEQ ID NO: 1; b) a polypeptide encoded by a polynucleotide having at least 87% identity with SEQ ID NO:2; or c) a fragment of a polypeptide of a) or b) which fragment has xylana…
Who is the assignee on this patent?
Dupont Nutrition Biosci Aps
What technology area does this patent fall under?
Primary CPC classification C12N9/2482. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).